Atossa Therapeutics Inc (NASDAQ:ATOS) shares, rose in value, with the stock price up by 10.05% to the previous day’s close as strong demand from buyers drove the stock to $2.03.
Actively observing the price movement in the last trading, the stock closed the session at $1.84. The value of beta (5-year monthly) was 1.16. Referring to stock’s 52-week performance, its high was $2.11, and the low was $0.59. On the whole, ATOS has fluctuated by 98.53% over the past month.
With the market capitalization of Atossa Therapeutics Inc currently standing at about $253.73 million, investors are eagerly awaiting this quarter’s results, scheduled for May 13, 2024 – May 17, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.06, which is expected to increase to -$0.06 for fiscal year -$0.27 and then to about -$0.3 by fiscal year 2025. Data indicates that the EPS growth is expected to be -12.50% in 2025, while the next year’s EPS growth is forecast to be -11.10%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that ATOS’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ATOS currently trading nearly 36.82% and 75.98% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 73.36, while the 7-day volatility ratio is showing 12.76% which for the 30-day chart, stands at 12.80%. Furthermore, Atossa Therapeutics Inc (ATOS)’s beta value is 1.24, and its average true range (ATR) is 0.17.
A comparison of Atossa Therapeutics Inc (ATOS) with its peers suggests the former has fared considerably weaker in the market. ATOS showed an intraday change of 10.05% in last session, and over the past year, it grew by 179.35%%.
Data on historical trading for Atossa Therapeutics Inc (NASDAQ:ATOS) indicates that the trading volumes over the past 10 days have averaged 2.8 million and over the past 3 months, they’ve averaged 1.05 million. According to company’s latest data on outstanding shares, there are 125.30 million shares outstanding.
Nearly 0.02% of Atossa Therapeutics Inc’s shares belong to company insiders and institutional investors own 19.14% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.48 million shares as on Mar 15, 2024, resulting in a short ratio of 9.57. According to the data, the short interest in Atossa Therapeutics Inc (ATOS) stood at 6.77% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 7.04 million. The stock has risen by 130.11% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ATOS stock heading into the next quarter.
